Src inhibition modulates AMBRA1-mediated mitophagy to counteract endothelial-to-mesenchymal transition in renal allograft fibrosis

Abstract

Chronic allograft dysfunction (CAD) poses a significant challenge in kidney transplantation, with renal vascular endothelial-to-mesenchymal transition (EndMT) playing a vital role. While renal vascular EndMT has been verified as an important contributing factor to renal allograft interstitial fibrosis/tubular atrophy in CAD patients, its underlying mechanisms remain obscure. Currently, Src activation is closely linked to organ fibrosis development. Single-cell transcriptomic analysis in clinical patients revealed that Src is a potential pivotal mediator in CAD progression. Our findings revealed a significant upregulation of Src which closely associated with EndMT in CAD patients, allogeneic kidney transplanted rats and endothelial cells lines. In vivo, Src inhibition remarkably alleviate EndMT and renal allograft interstitial fibrosis in allogeneic kidney transplanted rats. It also had a similar antifibrotic effect in two endothelial cell lines. Mechanistically, the knockout of Src resulted in an augmented AMBRA1-mediated mitophagy in endothelial cells. We demonstrate that Src knockdown upregulates AMBRA1 level and activates mitophagy by stabilizing Parkin’s ubiquitination levels and mitochondrial translocation. Subsequent experiments demonstrated that the knockdown of the Parkin gene inhibited mitophagy in endothelial cells, leading to increased production of Interleukin-6, thereby inducing EndMT. Consequently, our study underscores Src as a critical mediator of renal vascular EndMT and allograft interstitial fibrosis, exerting its impact through the regulation of AMBRA1/Parkin-mediated mitophagy.

References

[1] HartA, Lentine KL, SmithJM, et al. OPTN/SRTR 2019 annual data report: kidney. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2021;21(suppl 2):21-137.

[2] MalufDG, MasVR, ArcherKJ, et al. Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis. Mol Med. 2008;14:276-285.

[3] YangC, QiR, YangB. Pathogenesis of chronic allograft dysfunction progress to renal fibrosis. Adv Exp Med Biol. 2019;1165:101-116.

[4] BoorP, FloegeJ. Renal allograft fibrosis: biology and therapeutic targets. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2015;15:863-886.

[5] LiuBC, TangTT, LvLL, LanHY. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 2018;93:568-579.

[6] VanhoveT, Goldschmeding R, KuypersD. Kidney fibrosis: origins and interventions. Transplantation. 2017;101:713-726.

[7] GranataS, Benedetti C, GambaroG, ZazaG. Kidney allograft fibrosis: what we learned from latest translational research studies. J Nephrol. 2020;33:1201-1211.

[8] Jourde-ChicheN, Fakhouri F, DouL, et al. Endothelium structure and function in kidney health and disease. Nat Rev Nephrol. 2019;15:87-108.

[9] DejanaE, Hirschi KK, SimonsM. The molecular basis of endothelial cell plasticity. Nat Commun. 2017;8:14361.

[10] ZeisbergEM, Tarnavski O, ZeisbergM, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med. 2007;13:952-961.

[11] LiZ, ChenB, DongW, et al. MKL1 promotes endothelial-to-mesenchymal transition and liver fibrosis by activating TWIST1 transcription. Cell Death Dis. 2019;10:899.

[12] LiS, YuL, HeA, LiuQ. Klotho inhibits unilateral ureteral obstruction-induced endothelial-to-mesenchymal transition via TGF-β1/Smad2/Snail1 signaling in mice. Front Pharmacol. 2019;10:348.

[13] GloverEK, JordanN, SheerinNS, Ali S. Regulation of endothelial-to-mesenchymal transition by MicroRNAs in chronic allograft dysfunction. Transplantation. 2019;103:e64-e73.

[14] WangZ, HanZ, TaoJ, et al. Role of endothelial-to-mesenchymal transition induced by TGF-β1 in transplant kidney interstitial fibrosis. J Cell Mol Med. 2017;21:2359-2369.

[15] TangC, Livingston MJ, LiuZ, DongZ. Autophagy in kidney homeostasis and disease. Nat Rev Nephrol. 2020;16:489-508.

[16] LiH, PengX, WangY, et al. Atg5-mediated autophagy deficiency in proximal tubules promotes cell cycle G2/M arrest and renal fibrosis. Autophagy. 2016;12:1472-1486.

[17] NamSA, KimWY, KimJW, et al. Autophagy attenuates tubulointerstital fibrosis through regulating transforming growth factor-β and NLRP3 inflammasome signaling pathway. Cell Death Dis. 2019;10:78.

[18] LivingstonMJ, DingHF, HuangS, Hill JA, YinXM, DongZ. Persistent activation of autophagy in kidney tubular cells promotes renal interstitial fibrosis during unilateral ureteral obstruction. Autophagy. 2016;12:976-998.

[19] ChenX, WangL, DengY, et al. Inhibition of autophagy prolongs recipient survival through promoting CD8(+) T cell apoptosis in a rat liver transplantation model. Front Immunol. 2019;10:1356.

[20] TakagakiY, LeeSM, DongqingZ, Kitada M, KanasakiK, KoyaD. Endothelial autophagy deficiency induces IL6 -dependent endothelial mesenchymal transition and organ fibrosis. Autophagy. 2020;16:1905-1914.

[21] PanJA, ZhangH, LinH, et al. Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells. Redox Biol. 2021;46:102120.

[22] ZhuH, ZhongS, YanH, et al. Resveratrol reverts Streptozotocin-induced diabetic nephropathy. Front Biosci. 2020;25:699-709.

[23] WangX, RenR, XuZ, HuangH, JiangW, Ma J. Tirbanibulin attenuates pulmonary fibrosis by modulating Src/STAT3 signaling. Front Pharmacol. 2021;12:693906.

[24] SeoHY, LeeSH, LeeJH, et al. Src inhibition attenuates liver fibrosis by preventing hepatic stellate cell activation and decreasing connective tissue growth factor. Cells. 2020;9:558.

[25] YanY, MaL, ZhouX, et al. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis. Kidney Int. 2016;89:68-81.

[26] PakES, UddinMJ, HaH. Inhibition of Src Family Kinases Ameliorates LPS-Induced Acute Kidney Injury and Mitochondrial Dysfunction in Mice. Int J Mol Sci. 2020;21:8246.

[27] TaniguchiK, XiaL, GoldbergHJ, et al. Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice. Diabetes. 2013;62:3874-3886.

[28] HaasM, LoupyA, LefaucheurC, et al. The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2018;18:293-307.

[29] GuiZ, SuoC, WangZ, et al. Impaired ATG16L-dependent autophagy promotes renal interstitial fibrosis in chronic renal graft dysfunction through inducing EndMT by NF-κB signal pathway. Front Immunol. 2021;12:650424.

[30] DingQ, XieXL, WangMM, et al. The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis. Exp Mol Med. 2019;51:1-13.

[31] Di RienzoM, Romagnoli A, CiccosantiF, et al. AMBRA1 regulates mitophagy by interacting with ATAD3A and promoting PINK1 stability. Autophagy. 2022;18:1752-1762.

[32] JordanSC, ChoiJ, KimI, et al. Interleukin-6, a cytokine critical to mediation of inflammation, autoimmunity and allograft rejection: therapeutic implications of IL-6 receptor blockade. Transplantation. 2017;101:32-44.

[33] DobererK, DuerrM, HalloranPF, et al. A randomized clinical trial of anti-IL-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection. J Am Soc Nephrol. 2021;32:708-722.

[34] PonticelliC, Campise MR. The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation. Kidney Int. 2021;100:536-545.

[35] KimuraT, IsakaY, YoshimoriT. Autophagy and kidney inflammation. Autophagy. 2017;13:997-1003.

[36] UnverN, McAllister F. IL-6 family cytokines: key inflammatory mediators as biomarkers and potential therapeutic targets. Cytokine Growth Factor Rev. 2018;41:10-17.

[37] PengX, WangY, LiH, et al. ATG5-mediated autophagy suppresses NF-κB signaling to limit epithelial inflammatory response to kidney injury. Cell Death Dis. 2019;10:253.

[38] BarreraMJ, Aguilera S, CastroI, et al. Tofacitinib counteracts IL-6 overexpression induced by deficient autophagy: implications in Sjögren’s syndrome. Rheumatology. 2021;60:1951-1962.

[39] FilomeniG, De ZioD, CecconiF. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 2015;22:377-388.

[40] Di LuigiL, Sgrò P, DurantiG, et al. Sildenafil reduces expression and release of IL-6 and IL-8 induced by reactive oxygen species in systemic sclerosis fibroblasts. Int J Mol Sci. 2020;21:3161.

RIGHTS & PERMISSIONS

2024 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.